Vaccitech
Guiding the immune system to cure disease
Oxford, United Kingdom · Founded 2016 · $206.4M raised
- Headquarters
- Oxford
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- vaccitech.co.uk
- Total Funding
- $206.4M
- Last Round
- $168.0M Series BMar 2021
- Rounds
- 3
About
Barinthus Biotherapeutics (fka Vaccitech) is a clinical-stage biopharma advancing immunotherapies that guide T cells to treat autoimmunity, cancer, and infectious diseases using their SNAP-TI platform.
Summary
Vaccitech is a Biotech company based in Oxford, United Kingdom, founded in 2016. It has raised $206.4M in total across 3 rounds, most recently a $168.0M Series B round in Mar 2021. Investors include M&G Investments, GV and Sequoia China.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company